Adenocarcinoma of the penis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

7Recruiting trials

Regulatory Watchboard

9 events

Aug 2025E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Christian Hinrichs — PHASE1, PHASE2

TrialRECRUITING

Aug 2025Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Jonsson Comprehensive Cancer Center — PHASE1

TrialRECRUITING

Nov 2024Ivonescimab in the Treatment of Multiple Advanced Tumors

Fudan University — PHASE2

TrialRECRUITING

Mar 2023E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Christian Hinrichs — PHASE2

TrialRECRUITING

Oct 2022A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

National Cancer Institute (NCI)

TrialRECRUITING

Sep 2019Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

University of Utah — PHASE2

TrialACTIVE NOT RECRUITING

May 2019Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING

Dec 2017Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Dana-Farber Cancer Institute — PHASE2

TrialACTIVE NOT RECRUITING

Jul 2015Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

National Cancer Institute (NCI) — PHASE1

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Adenocarcinoma of the penis.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Abraxane

(paclitaxel protein-bound particles)Orphan drugstandard

Abraxis BioScience, LLC

Microtubule Inhibitor [EPC]

12.1 Mechanism of Action ABRAXANE is a microtubule inhibitor that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubule...

View full treatment details on disease page →

Clinical Trial Landscape

7 active trials

4Phase 2

2Phase 1

1PHASE1, PHASE2

7Total recruiting

Search clinical trials for Adenocarcinoma of the penis →

Recent News & Research

No recent news articles indexed yet for Adenocarcinoma of the penis.
Search PubMed for Adenocarcinoma of the penis →

Browse all Adenocarcinoma of the penis news →

Specialist Network

Top 6 by expertise

Andrea B Apolo, M.D., MD

National Cancer Institute (NCI)

📍 BETHESDA, MD

Score 179 trials

Andrea B Apolo

National Cancer Institute LAO

📍 Birmingham, Alabama

Score 174 trials

Hongxia Wang, Doctor

Fudan University

Score 162 trials

Aung Naing

M.D. Anderson Cancer Center

Score 102 trials

Camila MV Moniz, Doctor

Oncologist

📍 SAN ANTONIO, TX

Kanwal P Raghav, MD, M.D

M.D. Anderson Cancer Center

📍 HOUSTON, TX

View all Adenocarcinoma of the penis specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles